Oral and Esophageal Brush Biopsy (CPB 0686, reviewed 2026-10-15)
Effective date
Not stated in the notice
Identified
Oct 23, 2026
Summary
Aetna Clinical Policy Bulletin 0686 on oral and esophageal brush biopsy was last reviewed on 10/15/2026. It considers oral brush biopsy (OralCDx) with or without MAGE-A or GLUT-1 staining, esophageal brush biopsy (WATS3D, formerly EndoCDx), DNA-image cytometry, RNA-based oral brush biopsy, salivary miRNAs and esophageal balloon cytologic sampling experimental, investigational or unproven because their effectiveness has not been established, for screening, diagnosis or surveillance. The policy lists CPT 88104 and 99000, HCPCS D0486 and D7288, and several ICD-10 codes, including Z12.81, as not covered for the indications it lists.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.